Drug safety leaders speak:
There are thousands of small pharma and biotech companies around the world. Yet when it comes to drug safety, these organizations often struggle to source specialist support that addresses the unique challenges they face.
From April to June 2023, we undertook a roundtable series ‘Drug safety in small pharma and biotech’ with leaders holding pivotal pharmacovigilance roles.
The following report is a summary of the challenges and recommendations for practical solutions to serve this diverse and vastly underserved segment.